ANTIVIRAL:
Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak platform that couple potent antivirals to a human antibody fragment. These long-acting, antiviral conjugates (AVCs) directly inhibit viral proliferation while simultaneously engaging the immune system to maximize viral clearance.
AVCs have the potential to treat and prevent other life-threatening viruses, including RSV, HIV and SARS-CoV-2. Preclinical and discovery efforts are ongoing.
Subscribe here for updates.
